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Abstract
We investigated the integrated eects of an aerobic training program on circulatory levels of the metabotrophic factors (metabo-
trophins) nerve growth factor (NGF), brain derived neurotrophic factor (BDNF) and insulin like growth factor-1 (IGF-1), and 
anabolic state (testosterone/cortisol ratio) in middle aged males with metabolic syndrome (MetS). Thirty subjects (age: 58.23 
± 5.25 years, weight: 95.00 ± 8.26 kg, height: 173 ± 7.03 cm, VO
2peak
: 19.96 ± 4.18 ml kg.min-1) were randomized into exercise 
(n=16) and control, non-exercised (n=14) group.  The exercise group participated in eight weeks of aerobic training program (3 
sessions/week at 50%-60% of VO
2 
peak). Fasting blood samples were taken at baseline and after training and VO
2 
peak, insulin 
sensitivity and an overall metabolic syndrome Z score (Z MetS) were calculated. Aerobic training signicantly increased insulin 
sensitivity, Vo2 peak, plasma HDL and serum levels of NFG, BDNF, IGF-1 and testosterone (P<0.05) as compared to control pa-
tients. Additionally, there were signicant decreases in body weight, mean atrial pressure, waist circumference, plasma glucose 
and triglyceride and also serum cortisol levels (P<0.05) in training patients. Body weight, waist circumference, and NGF levels 
were recognized as the most important predictors for the 80% of variability in serum testosterone/cortisol ratio (P<0.05). An 
integrated metabotrophic and anabolic eect of aerobic training in patients with MetS was established. Early measurement of 
these variables may have prognostic benets for at risk population who progress to the generalized stage of cardiometabolic 
abnormalities. 
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Introduction
In accordance with the United States National Cholesterol 
Education Program’s Adult Treatment Рanel III (ATP III) the 
metabolic syndrome (MetS) is a cluster of cardiometabolic risk 
factors in one individual, including elevated blood pressure, 
dyslipidemia, impaired glycemic control, and abdominal 
obesity (1, 2). A high prevalence of MetS is repeatedly observed 
in patients with a low testosterone level and the reduced 
testosterone can adversely a!ect many of MetS components (3). 
"erefore, an increased attention was recently directed to clarify 
the probability of a disbalanced serum testosterone as a risk 
factor for MetS (4).
On the other hand, the classical neurotrophins nerve growth 
factor (NGF) and brain-derived neurtrophic factor (BDNF) 
were recently also recognized to mediate metabotrophic e!ects 
on glucose, lipid and energy homeostasis (5-7). Accordingly, a 
metabotrophic de#cit due to the reduced circulating levels of 
NGF and BDNF was implicated in the pathogenesis of advanced 
MetS (7, 8). Circulatory metabotrophins can also be in$uenced 
by stressful events (9) which preceded the increased cortisol 
levels (10). In a recent review it was concluded that chronic 
exercise may decrease the serum cortisol level in older people 
and recommended that future studies should seek to determine 
possible types of exercise to decrease cortisol levels in those with 
cardiometabolic diseases (11). 
Additionally, insulin-like growth factor-1 (IGF-1) as a 
protein with neurotrophic (12) and insulin-like, metabolic (13) 
properties is also considered to be of major importance for 
mediating the bene#ts of physical activity on the health status 
and metabolism as well as other neurotrophic factors (14, 15). 
"erefore, it is expected that the consequence of metabolic, 
neurotrophic and anabolic e!ects of exercise could be manifested 
in circulating IGF-1. IGF-1 levels was found to be consistently 
reduced in individuals with MetS and/or its components and its 
reduction could potentially impact on risk for MetS (16).  
Clinical intervention studies have also revealed that aerobic 
training clearly decreases cardiometabolic risk factors (17, 18). 
However, whether the metabotrophic reserve of the organism 
is in$uenced by the e!ects of aerobic training on MetS 
components still remains to be elucidated. On that background, 
we investigated whether a link between testosterone/cortisol 
ratio, an overall state of MetS and serum level of NGF, BDNF 
and IGF-1 could exist in middle aged man and how an aerobic 
training program could modify these variables? 
Subjects and Methods
"e study was approved by the local ethics committee of 
the University of Tehran (Clinical Trial ID: 2099660, Date: 
7/11/2013) and performed according to the principles of the 
Declaration of Helsinki. "e study was started a&er signing an 
informed consent document for participation in the research 
study by all the subjects. 
"irty volunteer sedentary obese middle aged (50-65 years) 
men underwent physical and clinical screens. "e mean arterial 
pressure (MAP), electrocardiogram (ECG), fasting blood sugar 
(FBS), blood lipid pro#le, creatinine, and complete blood 
count (CBC) were monitored. Waist circumference of ≥91.5 
cm was obligatory for a diagnosis of MetS (19). In addition to 
abdominal obesity, any 2 of the following 3 abnormalities should 
be observed: (i) dyslipidemia: triglyceride level ≥150 mg/dL or 
HDL cholesterol level <40 mg dL-1 or use of antidyslipidemia 
medication, (ii) hypertension: systolic blood pressure ≥130 
mm Hg or diastolic blood pressure ≥85 mm Hg or use of 
antihypertensive medication, and (iii) hyperglycemia: fasting 
plasma glucose level ≥110 mg/dL or use of hypoglycemia 
medication.
Exclusion criteria were smoking, alcohol drinking, sleep 
disorders, current insulin therapy; changes during the previous 
two months in oral hypoglycemic, antihypertensive, or lipid-
lowering agents or body weight (5%); serum creatinine level of 
(2.26 mg/dL) or greater; proteinuria greater than 1 g day-1; blood 
pressure greater than 160/100 mmHg; restrictions in physical 
activity because of disease or presence of other problems. Some 
of the participants were taking a range of medications, including 
beta blockers (n=5), statins (n=5), and metformin (n=4).
Study protocol: "e subjects were divided randomly into two 
groups including exercise (N=16, Weight: 94.31±7.80 kg, Height: 
173±6.8 cm, Age: 57.93±5.14 yrs.) and control (N=14, Weight: 
95.78±7.97 kg, Height: 173±7.4 cm, Age: 55.78±5.36 yrs.). "eir 
characteristics are shown in Table 1. All the subjects performed 
a graded exercise test (GXT) to exhaustion level to determine 
their O2 peak by standard method explained elsewhere (20). 
Waist circumference (WC), weight and height were measured 
using standard techniques. Blood pressure was recorded using 
a standard mercury sphygmomanometer on three occasions 
separated by intervals of 2 minutes; the average of the last two 
measures was used in the analysis.
Fasting blood samples were taken at baseline and a&er 
training (the second sample was taken 15 hours a&er the last 
training session). Plasma FBS, HDL cholesterol, and triglyceride 
levels were determined by enzymatic kits (Parsazmun, Karaj, 
Iran). Serum BDNF, NGF, IGF-1 and insulin were assayed in 
duplicate according to the manufacturers’ instructions (BDNF 
ELISA kit, R&D Systems, Minneapolis, Minnesota; NGF 
DuoSet ELISA kit, R&D Systems; IGF-1 Quantikine ELISA 
kit, R&D Systems; Insulin Diagnostic Related Groups ELISA 
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30.65±1.55 *31.36±1.3331.59±1.7331.65±1.66Body Mass index (kg m2-1)
23.43+4.97*19.81+4.2719.92+3.9120.14 +4.24Relative VO2 peak (mL kg.min-1)
101.75±4.66*106±5.41106.28±6.55106.85±6.50Waist circumference (cm)
100.29±5.81*106.18±6.76102.13±7.29105.30±7.83Mean Arterial Pressure (mmHg)
110.96±16.79*124.05±22.62123.64±22.23128.00±24.92Fasting blood sugar (mg dl-1)
196.56±82.38*222.43±80.84240.92±76.05227.85±77.16Triglyceride (mg dl-1)
45.31±8.45*38.31±5.0437.06±6.839.25±6.28High density lipoprotein (mg dl-1)
1744.59±504.68*1674.15±526.981854.46±343.131838.62±324.17Brain-derived neurotrophin factor (pg mL-1)
153.18±41.34*128.81±40.24136.14±33.22135±38.80Insulin like growth factor-1 (ng mL-1)
95.24±27.15*64.27±21.8268.71±20.2663.97±22.38Nerve growth factor (pg mL-1)
5.12±1.45*3.91±1.013.92±1.133.75±1.09Testeterone (ng dL-1)
304.18±77.92*332.62±96.67335.85±86.69337.64±100.66Cortisol  (nmol L-1)
0.0182±0.006*0.0128±0.00520.0123±0.00420.0118±0.0045Testeterone/ Cortisol 
1.66±2.64 *5.44±2.204.78±2.434.78±2.37Overall MetS z Score
19.81±4.6020.12±4.7619.38±2.4920.13±3.09Insulin (µIU/ml)
5.79±2.03 *6.46±2.065.56±0.976..05±1.38HOMA index
2086.79±222.452183.41±403.812205±353.722234.76±386.36Average Daily caloric intake
572.58±106.43560.27±189.30528±150.45508.50±161.53Daily Calories from proteins
1089.22±140.091118.47±186.721111.92±222.781108±232.85Calories from carbohydrates
466.85±166.61504.66±212.64580.07±157.39618.26±180.53Daily Calories from lipids
Values are given as mean (S.D.). *P<0.05 versus baseline in Exercise group
Table 1. Subject characteristics and description of the variables
kit, Hamburg, Germany). Cortisol and total testosterone were 
assayed using commercial kits (Diagnostic Systems Laboratories, 
Webster, TX). For total testosterone, the minimum detection 
limit was 0.03 nmol/L; intraassay and interassay CVs for three 
dierent concentrations were less than 9.6% and less than 9.1%, 
respectively.
A modied Z score (overall MetS Z score) was calculated for 
each variable using individual subject data, the United States 
National Cholesterol Education Program’s Adult Treatment 
Panel (ATP) III criteria, and standard deviations using data from 
the both groups at each step (21). !e equation used to calculate 
the MetS Z score at baseline for exercise group was as follows: 
Overall MetS Z-Score(Zmets) = [(40 – HDL)/5.04] + [(TG 
− 150)/80.84] + [(fasting blood glucose − 110)/22.62] + [(waist 
circumference – 91.5)/5.41] + [(mean arterial pressure − 
100)/6.76].  
Sum of the number of ATP III criteria met (without rely on 
medication use) in the baseline and a$er training was determined 
for each subject (21). To estimate overall insulin sensitivity, the 
homeostasis assessment model (HOMA index) was used.
Participants received a kitchen scale (Model: Hedieh, IRAN) 
and recorded their diet in detail for two weekdays and a weekend 
day (three and one week prior to the study beginning and also at 
4th and 6th weeks. !e logs were analyzed by Nutrition analyzer 
so$ware N4. 
!e exercise group followed an 8-week aerobic training 
program (3 sessions per week; 25-40 minutes walking, running 
by 50%-60% of the heart rate measured at O2 peak point in 
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GXT (totally 123.17 ± 9.17 km, adherence to training: 88.34 
± 7.85 %). Training sessions were performed in the Exercise 
Physiology Laboratory at the same time of day (4-6 pm), 
beginning with 10 min warm-up and ending with 10 min cool-
down. Heart rate monitors (Polar Electro Oy, Kempele, Finland) 
were used to adjust workload to achieve the target heart rate. 
Participants progressed from 25 minute/session at 50% of the 
O2 peak to 40 min/session at 60% of the O2 peak. Individual 
exercise supervision was provided for each session. All exercise 
training sessions were supervised by study sta!, and all the 
subjects exercised for a similar amount of time.
Statistical analysis: Pearson correlation coe"cient was 
used to assess correlations between the variables. All baseline 
variables were compared between exercise and control groups 
by means of independent samples T test. By using 2×2 repeated 
measure ANOVA, we tested the e!ects of training over the time 
between each of two groups. A stepwise multiple regression 
analysis was performed to identify the independent predictors 
of testosterone/cortisol ratio and Zmets. Statistical signi$cance 
was set at P<0.05 and all analyses were performed using the 
SPSS/PC package.
Results
No signi$cant intergroup di!erences were observed at baseline 
variables (P>0.05). Correlation analysis showed signi$cant 
relationships between testosterone/cortisol ratio with weight 
(r=-0.64, P=0.001), waist circumference (r=-0.76, P=0.001) 
NGF (r=0.65, P=0.001), IGF-1 (r=0.60, P=0.001), Insulin (r= 
-0.63, P=0.001) and HOMA-IR (r=-0.62, P=0.001), but not to 
Zmets (r= -0.18, P=0.32), age(r= -0.22, P=0.22), BMI (r=-0.20, 
P=0.27), Vo2 peak(r=0.27, P=0.14) and BDNF (r=0.26, P=0.15) 
in whole population at baseline. Further analysis indicated that 
Z MetS was related to insulin (r=0.37, P=0.44), Mean Arterial 
Pressure (r=0.45, P=0.12), waist circumference (r=0.45, P=0.12), 
fasting blood sugar (r=0.53, P=0.002), triglyceride (r=0.50, 
P=0.004), but not to other variables (P>0.05). In a multiple linear 
regression analysis on baseline variable in which age, height, 
weight, BMI, BDNF, NGF, IGF-1, Insulin, HOMA-IR, Mean 
Arterial Pressure, waist circumference, fasting blood sugar, 
triglyceride, HDL cholesterol, and overall Z MetS were included 
as independent variables, waist circumference(Beta=-0.59, 
p=0.001), NGF (Beta=-0.3, p=0.013) and weight (Beta=-0.27, 
p=0.023), explained 80% of testosterone/cortisol ratio variability 
(SD of the estimate=0.0021, P=0.001). 
Aerobic training not only signi$cantly increased insulin 
sensitivity, Vo2 peak, serum NGF, BDNF, IGF=1 and testosterone; 
but also decreased all the metabolic risk factors, body weight, Z 
MetS, and serum cortisol level (P<0.05) (Table 1, 2).  
Discussion
&e results of the present study showed that exercise positively 
a!ects cardiometabolic risk factors, which is consistent with 
Control (N=14) Exercise (N=16)
Baseline After Training Baseline After Training
No. of Total Metabolic Risk Factors 56 55 67 44
Count % Count % Count % Count %
Subjects with 1 Risk Factors 0 0 0 0 0 0 3 18.8
Subjects with 2 Risk Factors 0 0 1 7.11 0 0 3 18.8
Subjects with 3 Risk Factors 3 21.4 2 14.3 1 6.3 6 37.5
Subjects with 4 Risk Factors 8 57.1 8 57.1 11 68.8 3 18.8
Subjects with 5 Risk Factors 3 21.4 3 21.4 4 25 1 6.3
Subjects with WC>91.5 cm 14 100 14 100 16 100 16 100
Subjects with TG>150 mg dL-1 12 85.7 13 92.9 14 87.5 10 62.5
Subjects with HDL<40 mg dL-1 11 78.6 10 71.4 13 81.3 4 25
Subjects with BP>130/85 mmHg 10 71 9 64 12 75 8 50
Subjects with FBS>110 mg dL-1 9 64.3 9 64.3 12 75 6 37.5
Table 2.  Frequencies of the cardiometabolic risk factors
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previous studies (20) and emphasized on protective eects of 
aerobic training and clinical importance. Based on the negative 
relationships between baseline testosterone/cortisol ratio and 
body weight, waist circumference, insulin and HOMA-IR in 
whole population, we speculated that testosterone/cortisol ratio 
reduces with severity of obesity and insulin resistance in MetS 
subjects. In our study waist circumference was also recognized 
as the most important predictor of testosterone/cortisol ratio 
variability. Recently, among metabolic components for MetS, 
obesity has gained the most increased attention as a key 
symptom causing hypogonadism. Large cross-sectional surveys 
have also shown that the inverse association of testosterone 
with individual components of the MetS was the strongest for 
central adiposity and that among multiple health variables, 
increased waist circumference was the most closely associated 
with low testosterone (22). Other studies show that adiposity 
(23) and development of diabetes or the MetS accelerated the 
age-related decline in testosterone (24). Moreover, for most men 
early detection of a low serum testosterone (25) and/or NGF and 
BDNF (2) level was proposed to could be as the most reliable 
early marker for the eventual development of MetS. Of note, it 
is well known that during the discovery of NGF by Rita Levi-
Montalcini in the 1950’s it was established that the castration of 
male rats resulted in a signi!cant decrease of NGF secretion by 
submaxillary glands, a major rat source of NGF, that is, there is 
a positive correlation between testosterone and NGF levels (7, 8 
and references therein).
Although the mechanism for an association of low testosterone 
circulating level and obesity remains unclear, elevation of serum 
leptin associated with obesity speculated to inhibit gonadotropin-
stimulated androgen production (26). Moreover, increase in the 
peripheral aromatization of testosterone in adipose tissue in 
obese men also may be associated with low serum testosterone 
level through the feedback inhibition of pituitary luteinizing 
hormone secretion caused by elevated estrogen level (4). 
Both testosterone and testosterone/cortisol ratio were 
signi!cantly increased in our study a"er aerobic training 
which could be explained to some extent by weight loss. It was 
demonstrated that weight loss leads to substantial increases 
in total testosterone, especially in morbidly obese men, 
proportional to the amount of weight loss (27). Additionally, 
one study suggested that even small weight loss in only mildly 
overweight men was signi!cantly increased testosterone levels 
(28)  #is disproportionate increase in testosterone levels 
relative to weight loss may have occurred because weight loss 
was achieved by exercise. Several uncontrolled studies have 
shown that exercise itself can increase testosterone by up to 30% 
(29). 
#e declined cortisol level a"er training is another factor 
can explain an increased testosterone/cortisol ratio in this 
period. Patients with MetS has been found to have a state of 
“functional hypercortisolism” (11) and the higher cortisol in 
adipose tissue and liver might contribute to the development 
of several features of the MetS (30). A recent review was 
concluded that chronic exercise (mostly resistance exercises) 
may have positive in$uence on serum cortisol level in older 
people (11). However, little attention has been directed to the 
eects of aerobic training. Only two studies investigated old 
people and no statistically signi!cant changes in cortisol were 
observed in response to training (31, 32). #e exact mechanisms 
for declined cortisol level a"er training are still not understood 
well. Increased visceral adipose tissue leads to increased 
secretion of proin$ammatory cytokines, estradiol, insulin, and 
leptin, all of which may inhibit the activity of the hypothalamic-
pituitary-adrenal (HPA) axis at multiple levels (33). #erefore, 
it seems that decreased body fat could also be responsible to 
some extent for decreased cortisol level a"er aerobic training. 
Some authors have emphasized that hormonal changes can 
be in$uenced by factors such as stress, anxiety, psychological 
status, and the economic status of individuals (34). Moreover, 
local regeneration of cortisol is reported to be higher in adipose 
tissue of MetS patients with minimal eects on circulating levels 
(30). #erefore, including these variables can help control for 
these factors, and help researchers understand the mechanisms 
by which exercise in$uences the levels of serum cortisol (32)
In another part, serum insulin level was unchanged a"er 
aerobic training, while a declined HOMA-IR was observed. It 
could be indicated on improved glucose entrance to cells via 
exercise induced mechanisms (35) in our obese subjects with 
MetS who were highly insulin resistant at baseline (the cut o 
point for diagnosis of insulin resistance based on HOMA-IR 
was described as >2.5 (36). Waist circumference and abdominal 
obesity were recognized as the best simple anthropometric 
indices of the abdominal visceral adipose tissue accumulation 
and related cardiometabolic risk (37). A bidirectional 
relationship between visceral fat and testosterone was found to 
promote insulin resistance via increased in$ammatory cytokines 
(22) and other mechanisms involving muscle, liver and bones 
(22). #erefore, it seems that improved lifestyle factors or altered 
pharmacological management that increased testosterone levels 
also contributed to improved insulin sensitivity.
Further, we showed elevated serum IGF-1 a"er aerobic 
training. According to the existing evidence, the serum free 
IGF-I measurement was not always substantially altered a"er 
exercise (38) and the potential for this increase requires longer 
training duration (39). Circulating IGF-I is shown to be higher 
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in tter subjects and correlates with lean body mass (LBM) 
(38). e latter does not seem to change by our aerobic training, 
however, an elevated tness level aer training in exercise group 
(Δ%=18.57±9.41) is helpful to explain the observed changes 
in serum IGF-I level. IGF-1 has neurotrophic properties (12) 
with insulin-like eects that reduce blood glucose levels (13). 
erefore, its elevation aer aerobic training seems to have a 
major importance on the neurocognitive function in MetS. 
Both NGF and BDNF levels were also increased aer 
aerobic training.  ere is controversial  reports regarding the 
eects of aerobic training on serum BDNF in MetS and type 
2 diabetes, ranging from an increased (40), decreased (20, 41) 
or not altered (42) level of circulatory BDNF. Nerve growth 
factor is synthesized and released by white adipocytes and the 
level of the mRNA is reported to be higher in obese patients 
(43). However; lower plasma NGF was also demonstrated in 
morbidly obese subjects (43). Recently Damirchi et al (20) were 
reported a decreased serum BDNF levels aer aerobic training 
in MetS subjects. We attributed this controversy to the dierent 
MetS severity levels between two studies. In that research the 
cut o point for waist circumference was >102 cm instead of 
>91.5 cm in our study and they have not included medication 
use as a risk factor. Moreover, our subjects had higher overall 
MetS Z score and higher insulin resistance. erefore, we 
speculated that our subjects were in a more generalized stages 
of MetS. Hristova and Aloe (44) suggested that in early stage 
MetS hyperneurotrophinemia may represent a compensatory 
mechanism against a metin!ammatory state. However, in the 
advanced stage of MetS, these compensatory mechanisms fail 
and the resulted hyponeurotrophinemia may consequently 
contribute to the development of pathology of atherosclerosis 
and/or MetS (2, 7).
Plasma BDNF (45) and NGF (46) level has also found to 
decrease with age advancement and the exact reason for this 
decrease is still unclear. Considering that the prevalence of 
MetS, type 2 diabetes and obesity as individuals get older, it 
is possible that these metabotrophins’ functions as protective 
factors against cardiometabolic and cognitive disorders (47-
50), renders individuals more susceptible to these conditions. 
Whereas exercise-induced alterations in NGF and BDNF levels 
may exert both neuro- and metabotrophic eects (51-53). 
Conclusion
Taken as a whole, the results of this study emphasize on the 
metabotrophic eects of aerobic training for people with gen-
eralized MetS as it declines metabolic risk and serum cortisol, 
while increases NGF, BDNF, IGF-1 and testosterone. It seems 
early measurement of these variables could have prognostic 
benets for at risk population who progress to generalized MetS 
stage. Future studies should follow similar works by additional 
investigations on adipose tissue-derived neuro-metabotrophic 
factors (7, 54). 
Limitations in the present study. Our ndings should only 
be applied to men. We measured, only the fasting blood samples 
at 8 AM, which probably do not re!ect metabotrophins or 
steroids 24-hour and/or tissue levels, as an overexpression of 
steroids might be present in adipose tissue with minimal eect on 
circulation (34). Moreover, the circulatory neurotrophins might 
not to re!ect their actual cellular processing in whole body, i.e. 
synthesis, release, utilization, and degradation. We did not collect 
any measures of visceral adipose tissue, in!ammatory markers 
and cognitive function. e strengths of this study include a 
synchronal investigation on the eects of aerobic exercise on 
neurometabotrophins and corticosteroids in male MetS patients. 
We included an established cut o point for abdominal obesity 
in Iranian adults (>91.5 cm) as an obligatory criterion for MetS 
screening which enabled us to recruit more matched subjects as 
the classic methods (e.g. ATPIII criteria) may involve a spread 
spectrum of cardiometabolic risk factors (20). 
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